Middle East and Africa Pharmaceutical Isolator Market Growth and Forecast by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Middle East and Africa Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025886
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 137

The MEA pharmaceutical isolator market is expected to grow from US$ 258.00 million in 2021 to US$ 426.54 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2021 to 2028.



The UAE, Saudi Arabia, and South Africa are major economies in MEA. Burgeoning pharmaceutical and biotechnological industries is expected to surge the market growth. The expenditure on pharmaceutical research in MEA countries are growing. In addition, various countries in the region can adopt advanced technologies such as aseptic isolators. They are also engaged in the development of cost-effective and high-performance systems to become advanced drug developers in the region. Emerging countries would offer lucrative growth opportunities for the players in the market owing to their diversified healthcare markets, low labor, and raw material costs, rise in life science research activities, government support, the rapid growth of CROs and the pharmaceutical industries, and technological integration and advancements. The governments of emerging countries have also spent significantly on encouraging research in the pharmaceutical industry. Moreover, the increasing interest of pharmaceutical companies in drug discovery outsourcing due to the ever-increasing demand for better drugs, limited drug pipelines, and rise in R&D costs is further fueling the demand for aseptic isolators in emerging markets.  Furthermore, several MEA countries are emerging as attractive outsourcing locations for biopharmaceutical manufacturers across the region. Low manufacturing and operating costs in countries are key factors driving the pharmaceutical isolator growth in region. Moreover, recent developments in the biopharmaceutical industry indicate significant potential for the market. All the aforementioned factors would offer lucrative opportunities for the MEA pharmaceutical isolator market in emerging economies during the forecast period.

In case of COVID-19, MEA is highly affected especially South Africa. The coronavirus pandemic has become the largest challenge to this region, as they are low-cost regions. For instance, due to the high uncertainty of the spread of COVID-19, the impact on Africa is expected to be severe, given the continent’s exposure to China. These regions are widely dependent on the import of pharmaceutical and biopharmaceutical equipment. The lockdown situation in many countries has resulted in no trade in foreign countries. Thus, the countries in the MEA have started producing API in their domestic market. However, the cost of production was a challenge for several countries. The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region. Similarly, increasing incidence of COVID-19 create huge demand for aseptic processing of pharmaceutical products. This scenario is expected to offer several growth opportunities for pharmaceutical isolator market. In South Africa, adoption of aseptic processing during pandemic has significantly witnessed high growth, which is expected to increase the demand for pharmaceutical isolator market. For instance, Esco Technologies Pty Ltd has offered Esco Class II Biological Safety Cabinets to various laboratories and testing facilities in South Africa. Biosafety cabinets pose great importance in handling biohazards in COVID-19 testing facilities. All these factors will positively impact the pharmaceutical isolator market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA pharmaceutical isolator market. The MEA pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.
MEA pharmaceutical isolator market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MEA Pharmaceutical Isolator Market Segmentation        

MEA Pharmaceutical Isolator Market – By Type

  • Open Isolators
  • Closed Isolators

MEA Pharmaceutical Isolator Market – By Pressure

  • Positive Pressure
  • Negative Pressure

MEA Pharmaceutical Isolator Market – By Configuration

  • Floor Standing
  • Modular
  • Compact
  • Mobile

MEA Pharmaceutical Isolator Market – By Application

  • Aseptic
  • Sampling & Weighing
  • Fluid Dispensing
  • Containment    
  • Others

MEA Pharmaceutical Isolator Market – By End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals
  • Research and Academic Laboratories
  • Other

MEA Pharmaceutical Isolator Market, by Country

  • Saudi Arabia 
  • UAE 
  • South Africa
  • Rest of MEA

MEA Pharmaceutical Isolator Market -Companies Mentioned

  • Azbil Telstar
  • Bioquell (Ecolab Solution)
  • Comecer
  • Fedegari Autoclavi S.p.A.
  • Getinge AB 
  • Hosokawa Micron Group
  • Nuaire Inc.

Middle East and Africa Pharmaceutical Isolator Report Scope

Report Attribute Details
Market size in 2021 US$ 258.00 Million
Market Size by 2028 US$ 426.54 Million
Global CAGR (2021 - 2028) 7.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Open Isolator and Closed Isolator
By Pressure
  • Positive Pressure and Negative Pressure
By Configuration
  • Floor Standing
  • Modular
  • Mobile
  • Compact
By Application
  • Aseptic Isolators
  • Containment Isolators
  • Sampling and Weighing Isolators
  • Fluid Dispensing Isolators
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Azbil Telstar
  • Bioquell (Ecolab Solution)
  • Comecer
  • Fedegari Autoclavi S.p.A.
  • Getinge AB
  • Hosokawa Micron Group
  • Nuaire Inc.
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    1. Azbil Telstar
    2. Bioquell (Ecolab Solution)
    3. Comecer
    4. Fedegari Autoclavi S.p.A.
    5. Getinge AB
    6. Hosokawa Micron Group
    7. Nuaire Inc.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo